LaNova Medicines Zhejiang Co., Ltd.
3 clinical trials · Sponsor
◉ Watch LaNova Medicines Zhejiang Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma. (NCT06351020) | LaNova Medicines Zhejiang Co., Ltd. | 2024-06-24 |
| Study of LM-302 in Patients With Advance Solid Tumors (NCT05161390) | LaNova Medicines Zhejiang Co., Ltd. | 2021-11-26 |
Track LaNova Medicines Zhejiang Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.